Clinical Characteristics and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes: A Single-Center, Retrospective Study in Southern China
Table 1
Clinical risk factors of study participants.
Clinical risk factors
NDM group (n = 746)
DM group (n = 410)
Total (n = 1156)
value
Gender (male) (n, %)
527 (70.64%)
245 (59.76%)
772 (66.78%)
≤0.010
Age (mean ± SD; years)
64.85 ± 12.71
64.03 ± 10.48
64.56 ± 11.97
0.164
History of AIS (n, %)
165 (22.12%)
78 (19.02%)
243 (21.02%)
0.228
Smoking (n, %)
313 (41.96%)
139 (33.90%)
452 (39.10%)
0.008
Drinking (n, %)
105 (14.13%)
56 (13.69%)
161 (13.93%)
0.929
Hypertension (n, %)
477 (63.94%)
299 (72.93%)
776 (67.13%)
0.002
Atrial fibrillation (n, %)
36 (4.83%)
25 (6.10%)
61 (5.28%)
0.409
Coronary heart disease (n, %)
50 (6.70%)
39 (9.51%)
89 (7.70%)
0.106
Heart failure (n, %)
34 (4.56%)
10 (2.44%)
44 (3.81%)
0.078
TG (≥150 mg/dL) (n, %)
187 (25.08%)
176 (42.93%)
363 (31.40%)
≤0.010
TG (mean ± SD; mg/dL)
148.85 ± 518.22
183.40 ± 202.01
160.37 ± 433.25
≤0.010
TC (≥200 mg/dL) (n, %)
209 (28.02%)
103 (25.12%)
312 (26.99%)
0.300
TC (mean ± SD; mg/dL)
175.31 ± 49.03
147.06 ± 81.08
165.25 ± 63.70
≤0.010
LDL-C (≥130 mg/dL) (n, %)
313 (41.96%)
160 (39.02%)
473 (40.92%)
0.349
LDL-C (mean ± SD; mg/dL)
114.55 ± 53.83
101.01 ± 63.24
109.52 ± 57.66
0.005
Statins/fenofibrate use (n, %)
134 (17.96%)
61 (14.88%)
195 (16.87%)
0.190
. SD: standard deviation; NDM: no diabetes mellitus; AIS: acute ischemic stroke; TG: triglycerides; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol.
